4//SEC Filing
EBERT CHARLES D 4
Accession 0001179110-12-003877
CIK 0000884629other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:32 PM ET
Size
9.4 KB
Accession
0001179110-12-003877
Insider Transaction Report
Form 4
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
- Sale
Common Stock, par value $0.0033
2012-02-29$58.77/sh−1,000$58,772→ 26,264 total - Sale
Common Stock, par value $0.0033
2012-02-29$58.81/sh−3,981$234,127→ 22,283 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2012-02-29−1,000→ 0 totalExercise: $25.64From: 2010-09-01Exp: 2016-09-01→ Common Stock, par value $0.0033 (1,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0033
2012-02-29$25.64/sh+1,000$25,640→ 27,264 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeother
Related Parties
1- filerCIK 0001241752
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 4:32 PM ET
- Size
- 9.4 KB